] Shares ARGOS THERAPEUTICS, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • February 16th, 2012 • Argos Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 16th, 2012 Company Industry JurisdictionINTRODUCTION. Argos Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [ ] shares (the “Firm Shares”) of the common stock, $0.001 par value per share (the “Common Stock”), of the Company.